| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 4e-05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |